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The perioculomotor (pIII) region of the midbrain was
postulated as a sleep-regulating center in the 1890s
but largely neglected in subsequent studies. Using
activity-dependent labeling and gene expression
profiling, we identified pIII neurons that promote
non-rapid eye movement (NREM) sleep. Optrode
recording showed that pIII glutamatergic neurons
expressing calcitonin gene-related peptide alpha
(CALCA) are NREM-sleep active; optogenetic and
chemogenetic activation/inactivation showed that
they strongly promote NREM sleep. Within the pIII
region, CALCA neurons form reciprocal connections
with another population of glutamatergic neurons
that express the peptide cholecystokinin (CCK). Acti-
vation of CCK neurons also promoted NREM sleep.
Both CALCA and CCK neurons project rostrally to
the preoptic hypothalamus, whereas CALCA neu-
rons also project caudally to the posterior ventrome-
dial medulla. Activation of each projection increased
NREM sleep. Together, these findings point to the
pIII region as an excitatory sleep center where
different subsets of glutamatergic neurons promote
NREM sleep through both local reciprocal connec-
tions and long-range projections.INTRODUCTION
In the 1890s, Ludwig Mauthner proposed the existence of a
‘‘sleep center’’ near the oculomotor nucleus (III) in the midbrain,
based on his observations of human patients with sleep disor-
ders (Foley, 2018). Since then, the notion of a sleep center has
inspired numerous studies to identify the brain regions important
for sleep generation. However, the proposed role of theperioculomotor (pIII) region in sleep regulation has been largely
forgotten.
Following the pioneering work of von Economo (1930) and
Nauta (1946), most of the studies on sleep regulation have
focused on the preoptic area (POA) of the hypothalamus.
Lesions in the POA cause severe insomnia (Lu et al., 2000;
McGinty and Sterman, 1968; Sallanon et al., 1989); sleep-active
neurons have been observed in the POA using multiple tech-
niques (Alam et al., 2014; Gong et al., 2004; Sherin et al., 1996;
Szymusiak et al., 1998; Takahashi et al., 2009; Zhang et al.,
2015), and recent studies have begun to reveal their genetic
identities (Chung et al., 2017). In addition to the POA, sleep-
promoting neurons have also been observed in other brain
regions. For example, activation of gamma aminobutyric acid
(GABA)ergic neurons in the parafacial zone (Anaclet et al.,
2014), the ventrolateral periaqueductal gray (Weber et al.,
2015; Weber et al., 2018), the ventral tegmental area (VTA)
(Yang et al., 2018; Yu et al., 2019), or adenosine A2A receptor-ex-
pressing neurons in the striatum (Oishi et al., 2017; Yuan et al.,
2017) specifically promotes non-rapid eye movement (NREM)
sleep, whereas subgroups of GABAergic neurons in the lateral
hypothalamus (Jego et al., 2013; Konadhode et al., 2013; Tsune-
matsu et al., 2014) and the zona incerta (Liu et al., 2017) promote
both REM and NREM sleep. With the exception of nitrergic/
glutamatergic neurons in the median and medial preoptic area
that are excited by external warmth (Harding et al., 2018),
the vast majority of sleep-promoting neuronal populations are
GABAergic, and their sleep-promoting effects are likely medi-
ated by the inhibition of wake-promoting populations. Because
some sleep-promoting GABAergic neurons have been shown
to be preferentially active during sleep (Anaclet et al., 2014;
Hassani et al., 2009), an important question is whether there
are excitatory sleep-active neurons that provide input to these
GABAergic sleep neurons.
In this study, we performed global screening for sleep-active
neurons in the mouse brain using a newly developed activity-
dependent genetic labeling technique (Guenthner et al., 2013;
Ye et al., 2016). We found that calcitonin gene-related peptideCell 177, 1–15, May 16, 2019 ª 2019 Elsevier Inc. 1
CA
B
D
E F
Fold change IP/IN
1/8 1/4 1/2 1 2 4 8
10-5
10-4
10-3
10-2
10-1
100
p 
va
lu
e
Rpl10a
Calca
Gal
Calcb
2 4 8
10-4
10-3
10-2
p value
Fold change
 Neuropeptides
Magnetic
  beads
AAAAA
RS mice
Aq
mlf
Oculomotor (III) 
nucleus
Immunoprecipitation RNA-Seq
AAAAA
AAAAA
AAAAA
RS-eGFP Slc17a6 Overlay
Slc32a1 Overlay
Chat OverlayRS-eGFP
RS-eGFP
0
20
40
60
80
100
O
ve
rla
p/
R
S
-e
G
FP
 (%
)
Slc
32
a1
Calcb Calca
Overlay
RS-eGFP CalcaGal Calca
Overlay Overlay
/Gal+/Calca+
0
20
40
60
80
100
O
ve
rla
p 
(%
)
/Calca+ /Calcb+
0
20
40
60
80
100
O
ve
rla
p 
(%
)
/Calca+ /RS-
eGFP+
0
20
40
60
80
100
O
ve
rla
p 
(%
)
G
Fos CreER
eGFP-L10aSTOP
6 hr
SD
RS
Inject 4-OHT Sac
Sleep deprivation 
Inject 4-OHT
Recovery sleep
Sac
3 hr
SD RS
1-2 weeks
Slc
17
a6
Ch
at
X
III
EW
EW
III
Figure 1. Identification of Sleep-Active Neurons in the pIII Region
(A) Experimental schematic. Mice expressing CreER under the Fos promoter are crossed with Cre-inducible reporter mice expressing EGFP-L10a. Each mouse
undergoes 6 h of sleep deprivation (SD) and 3 h of recovery sleep (RS); 4-OHT was injected immediately before SD or RS to label wake- or sleep-active neurons,
respectively.
(B) EGFP expression in the pIII region. Left: coronal diagram of the mouse brain. A red square indicates the pIII region. Right: confocal images of EGFP-labeled
neurons in SD and RS mice at anterior posterior (AP) 3.8 mm. Blue, DAPI. Scale bar, 100 mm.
(legend continued on next page)
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https://doi.org/10.1016/j.cell.2019.03.041alpha (CALCA)-expressing neurons in the pIII region—the puta-
tive sleep center proposed by Mauthner—are preferentially
active during NREM sleep. Activation of pIII CALCA neurons
strongly promoted NREM sleep, and the effect is attributable
at least partly to the glutamatergic subpopulation. In addition,
cholecystokinin (CCK)-expressing glutamatergic neurons in the
pIII region also promote NREM sleep, and they form local recip-
rocal connections with CALCA neurons. The rostral projections
of both CALCA and CCK neurons to the POA and the caudal
projection of CALCA neurons to the ventromedial medulla all
promote NREM sleep, likely through their excitation of sleep-
promoting neurons in those areas. Together, these results point
to the pIII region as an excitatory sleep center where glutamater-
gic neurons promote NREM sleep through both local reciprocal
connections and long-range projections to other sleep-
promoting areas.
RESULTS
Identification of Sleep-Active Neurons in the pIII Region
Recovery sleep following several hours of sleep deprivation in-
duces robust Fos expression in sleep-active neurons (Anaclet
et al., 2012; Gong et al., 2004; Liu et al., 2017; Sherin et al.,
1996; Zhang et al., 2015). To gain genetic access to the sleep-
active neurons and to study their gene expression profiles, we
crossed a FosCreER transgenic mouse line that expresses
tamoxifen-inducible Cre recombinase under the Fos promoter
(Guenthner et al., 2013; Ye et al., 2016) with a Cre-dependent
eGFP-L10a reporter line that expresses the EGFP-tagged ribo-
somal protein L10a (Long et al., 2014). In one group of crossed
mice (n = 5), we paired an injection of 4 hydroxytamoxifen
(4-OHT) with recovery sleep (RS; following 6 h of sleep depriva-
tion). This allows the Cre estrogen receptor (CreER) expressed in
sleep-active neurons to enter the nucleus, leading to permanent
expression of EGFP-L10a (Figure 1A). In another group of mice
(n = 5), we paired a 4-OHT injection with sleep deprivation (SD)
to label wake-active neurons with EGFP-L10a.
We observed EGFP expression in multiple brain areas in both
RS and SD mice (Table S1), but the number of labeled neurons
differed between the two groups in several areas known to be
involved in sleep-wake regulation (Figure S1A). For example,
the tuberomammillary nucleus (TMN), VTA, parabrachial nucleus
(PB), and locus coeruleus (LC) contained more EGFP-labeled
neurons in SD mice, likely because of the abundance of wake-
active neurons in those areas (Aston-Jones and Bloom, 1981;
Eban-Rothschild et al., 2016; Kaur et al., 2017; Takahashi
et al., 2006, 2010). In contrast, the parafacial zone (PZ), the(C) RS-EGFP neurons consist of glutamatergic and cholinergic subpopulations. L
marker. Slc17a6, vesicular glutamate transporter 2;Chat, choline acetyltransferas
of RS-EGFP neurons in the pIII region that express Slc17a6, Chat, or Slc32a1. E
(D) Gene expression profiling of RS-EGFP neurons. Left: schematic of the experim
L10a (Rpl10a) as a positive control. Orange dots, neuropeptide genes. Calca, calc
Gal, galanin.
(E) Overlap betweenCalca andCalcbmRNA in the pIII region based on double FIS
The bar graph shows the percentages of Calca or Calcb neurons that are co-lab
(F) Similar to (E) for overlap between Calca and Gal (n = 5 mice).
(G) Overlap between RS-EGFP and Calca (n = 8 mice).
See also Figure S1 and Tables S1 and S2.lateral and dorsal paragigantocellular reticular nucleus (DPGi
and LPGi, respectively), and the lateral preoptic area (LPO)
showed more EGFP labeling in the RS group, likely because of
the REM or NREM sleep-active neurons found in those regions
(Anaclet et al., 2014; Chung et al., 2017; Verret et al., 2006;
Weber et al., 2015; Zhang et al., 2015). Interestingly, the brain
region with the highest relative expression in the RS group was
the pIII (Figures 1B and S1A–S1C), the area originally proposed
by Mauthner as a sleep center. This region contains the third
oculomotor nucleus and the nearby Edinger-Westphal nucleus.
Immunohistochemical staining confirmed strong Fos expression
in the pIII region of RS mice, and comparison of Fos and EGFP
expression demonstrated a high specificity (81.0% ± 2.3%,
SEM) of EGFP labeling of sleep-active neurons (Figure S1D).
Furthermore, very few EGFP-labeled neurons in RS mice
expressed Fos following SD (11.4% ± 2.1%) and vice versa
(3.2% ± 1.1%; Figure S1E), further demonstrating the specificity
of EGFP labeling.
Fluorescence in situ hybridization (FISH) showed that most
of the EGFP-labeled pIII neurons in the RS mice expressed
the glutamatergic marker Slc17a6 (encoding vGLUT2) or
the cholinergic marker Chat, whereas none expressed the
GABAergic marker Slc32a1 (encoding vGAT) (Figure 1C). On
the other hand, large fractions of glutamatergic (91.7% ±
1.3%, SEM) and cholinergic (87.8% ± 0.7%) neurons did not
express EGFP. To identify more specific markers for the
EGFP-labeled neurons, we performed gene expression
profiling using translating ribosome affinity purification (Ek-
strand et al., 2014; Heiman et al., 2008). The translating
mRNA was isolated by immunoprecipitation (IP) of the EGFP-
tagged L10a protein from tissue lysate using an anti-EGFP anti-
body. RNA sequencing (RNA-seq) revealed multiple genes
significantly enriched in the EGFP-labeled neurons relative to
the input RNAs (whole pIII lysate before immunoprecipitation)
(Figure 1D; Table S2). In particular, we found three highly en-
riched neuropeptides: CALCA and calcitonin gene-related pep-
tide beta (CALCB) together with galanin (GAL). Double FISH
showed a more than 80% overlap between Calca and Calcb
mRNAs (Figure 1E), indicating that the two closely related
mRNAs are largely co-expressed in the pIII region. In contrast,
Gal mRNA is expressed in a much smaller population of neu-
rons, 53.2% of which also express Calca (Figure 1F). We thus
focused on CALCA as a candidate marker. Double FISH of
EGFP and Calca showed that 66.0% ± 1.5% (SEM) of EGFP-
labeled pIII neurons in RS mice expressed Calca mRNA (Fig-
ure 1G), suggesting that CALCA could serve as an effective
marker for sleep-active neurons.eft: double fluorescence in situ hybridization (FISH) of EGFP and each neuronal
e; Slc32a1, vesicular GABA transporter. Scale bar, 100 mm. Right: percentages
ach circle indicates data from one mouse (n = 4 mice).
ent. Red square, brain region used for profiling. Right: volcano plot. Blue dot,
itonin gene-related peptide alpha; Calcb, calcitonin gene-related peptide beta;
H at AP3.8mm. Arrowheads indicate co-labeled neurons. Scale bar, 100 mm.
eled. Each circle indicates data from one mouse (n = 4 mice).
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Figure 2. CALCA Neurons in the pIII Region Are Preferentially Active during NREM Sleep
(A) Schematic of optrode recording in freely movingmice. Right: fluorescence image of the pIII region (red box in the coronal diagram at AP3.7mm) in aCalcaCre
mouse injected with AAV-EF1a-DIO-hChR2-eYFP.
(B) Example recording of spontaneous and laser-evoked spikes from an identified CALCA neuron. Top left: raw trace. Blue ticks, laser pulses. Top right:
comparison of laser-evoked (blue) and averaged spontaneous (red) spike waveforms. Bottom: spike raster showing multiple laser stimulation trials at 15
and 30 Hz.
(C) Firing rate of an example CALCA neuron (bottom) together with an EEG spectrogram, EMG trace, and brain states (color coded). Freq., frequency.
(D) Firing rates of 32 identified CALCA neurons during different brain states. Each line shows the firing rates of one neuron.
(E) Firing rate modulation of all identified CALCA (blue, n = 32 neurons from 13 mice) and unidentified (gray, n = 40 neurons from 14 mice) neurons in the
pIII region. Traces on the top and right show distributions of NREM-wake (top) and REM-wake (right) modulation for each population. The distributions of
(legend continued on next page)
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To directly measure the firing rates of pIII CALCA-expressing
neurons across sleep and wake states, we tagged them with
channelrhodopsin-2 (ChR2) and performed optrode recordings
(Anikeeva et al., 2011; Xu et al., 2015; Figure 2A). A Cre-inducible
adeno-associated virus (AAV) vector expressing ChR2 fused
with enhanced yellow fluorescent protein (eYFP) was injected
into the pIII region of a new line ofCalcaCremice (STARMethods).
During each recording session, high-frequency laser pulses (15
or 30 Hz, 10ms per pulse, 16 pulses per train) were applied inter-
mittently, and single units showing reliable laser-evoked spiking
at short latencies and low jitter were identified as CALCA
neurons (Figures 2B and S2). For each neuron, we recorded its
endogenous activity (outside of laser stimulation periods) across
multiple cycles of wake, REM, and NREM states, classified
based on electroencephalogram (EEG) and electromyogram
(EMG) recordings.
For the 32 identified CALCA neurons, the mean firing rate dur-
ing NREM sleep was significantly higher than those during wake-
fulness (p < 0.001, Wilcoxon signed-rank test) and REM sleep
(p < 0.001; Figures 2C–2E). Individually, 18 neurons showed
significantly higher rates during NREM sleep than wakefulness
(p < 0.05, Wilcoxon rank-sum test), and only 2 were significantly
more active during wakefulness; 19 neurons showed signifi-
cantly higher firing rates during NREM than REM sleep, and
only 5 were more active during REM sleep (Table S3). The firing
rates of CALCA neurons increased over 15 s before onset of
NREM sleep and decreased abruptly at the end of each NREM
episode (Figure 2F), allowing them to participate in both the initi-
ation and maintenance of NREM sleep. Compared with the
identified CALCA neurons, the 40 unidentified pIII neurons
showed a much higher degree of functional diversity, including
many units that were more active during wakefulness or REM
sleep (Figure 2E, gray symbols).
CALCA Neurons in the pIII Region Promote NREM Sleep
Next, to test the causal role of CALCA neurons in sleep regula-
tion, we bidirectionally manipulated their activity both optoge-
netically and chemogenetically. For optogenetic activation, laser
stimulation (20 Hz, 2 min/trial) was applied randomly every
10–14 min in mice expressing ChR2 in their pIII CALCA neurons
(Figure S3A). Activation of the CALCA neurons caused a strong
increase in NREM sleep while suppressing both wakefulness
and REM sleep (Figures 3A and 3B). Analysis of the probability
of transitions between each pair of brain states showed that
laser stimulation significantly enhanced wake / NREM and
NREM / NREM transitions and decreased NREM / wake,
wake / wake, and NREM / REM transitions (Figures S3C),
indicating enhancement of both the initiation and maintenance
of NREM sleep.NREM-wake modulation were significantly different between the identified and
REM; NR, NREM.
(F) Mean firing rate of all identified CALCA neurons at brain state transitions (n = 3
mean during the whole recording session before being averaged across neurons
See also Figure S2 and Table S3.In CalcaCre mice expressing the light-activated chloride chan-
nel iC++ (Berndt et al., 2016) in the pIII region, laser stimulation
(constant laser, 1 min/trial) strongly decreased NREM sleep
and increased wakefulness (Figures 3C, 3D, and S3B). This
was due to decreases in both wake / NREM and NREM /
NREM transitions and increases in NREM / wake and wake
/ wake transitions (Figure S3D). In control mice expressing
eYFP without ChR2 or iC++, laser stimulation had no effect (Fig-
ure S3E), and the changes in brain states induced by laser stim-
ulation were significantly different between the ChR2 and control
mice (p < 0.0001, bootstrap) and between iC++ and control mice
(p < 0.0001).
We also tested the effects of chemogenetic manipulations of
CALCA neurons (Sternson and Roth, 2014). For the activation
experiment, AAV-EF1a-double-floxed inverse orientation (DIO)-
hM3D(Gq)-mCherry was injected into the pIII region of CalcaCre
mice. Compared with vehicle injection, clozapine-N-oxide
(CNO) injection strongly increased NREM sleep and decreased
wakefulness (Figure 3E). In contrast, in mice expressing AAV-
EF1a-DIO-hM4D(Gi)-mCherry in their pIII CALCA neurons,
CNO injection increased wakefulness and decreased sleep (Fig-
ure 3F). In control mice expressing mCherry without hM3D(Gq)
or hM4D(Gi), CNO had no significant effect (Figure S3F).
To further assess the functional importance of pIII CALCA neu-
rons, we ablated them by expressing a designer pro-caspase-3
(pro-taCasp3), whose activation causes apoptosis, and tobacco
etch virus protease (TEVp), which activates pro-caspase-3
(Yang et al., 2013). Injection of AAV-EF1a-DIO-taCasp3-TEVp
into the pIII region of CalcaCre mice caused a strong reduction in
CALCA-expressing neurons (Figure S3G). Compared with their
control littermates, mice with CALCA neuron ablation showed a
markeddecrease inNREMsleepduringboth the light anddarkpe-
riods (FigureS3H). TheNREMsleep reductionwasevenmorepro-
nouncedduring the recovery period following 5 h of sleepdepriva-
tion (Figure S3I). These results further support the functional
importance of pIII CALCA neurons in NREM sleep generation.
Functional Distinction between Glutamatergic and
Cholinergic Neurons
Because the EGFP-labeled sleep-active population consists of
both glutamatergic and cholinergic neurons (Figures 1C), we
wondered whether CALCA-expressing neurons are similarly
heterogeneous. FISH of Slc17a6, Chat, and Calca showed that
the CALCA population indeed contains both glutamatergic
(66.6% ± 0.6%, SEM) and cholinergic (35.9% ± 1.0%) neurons
(with a small overlap between Slc17a6 and Chat expression)
(Figure 4A). This raises the question of whether the NREM-
promoting effect of CALCA neurons is mediated by the glutama-
tergic or cholinergic subpopulation.
To test the function of cholinergic neurons, we injected Cre-
inducible AAV-expressing ChR2-eYFP into ChatCre mice (Rossiunidentified populations (p < 0.001, Kolmogorov-Smirnov test). W, wake; R,
2 neurons from 13 mice). The firing rate of each neuron was normalized by its
. Time 0 indicates the transition point. Shading, ± SEM.
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Figure 3. Optogenetic and Chemogenetic Manipulations of pIII CALCA Neurons
(A) An example optogenetic activation experiment in a CalcaCre mouse with AAV-EF1a-DIO-hChR2-eYFP injected into the pIII region. Shown are an EEG
spectrogram, EMG trace, and brain states (color-coded). Blue stripe, laser stimulation period (20 Hz, 120 s).
(B) Percentage of time in the NREM, REM, or wake state before, during, and after laser activation of CALCA neurons, averaged from 8 mice. Shading, 95%
confidence intervals (CIs). Blue stripe, laser stimulation period (20 Hz, 120 s). Laser stimulation significantly increased NREM sleep (p < 0.0001, bootstrap) and
decreased wakefulness (p < 0.0001) and REM sleep (p < 0.0001).
(C) An example optogenetic inactivation experiment in aCalcaCremousewith AAV-EF1a-DIO-iC++-eYFP injected into the pIII region. Blue stripe, laser stimulation
(constant illumination, 60 s).
(D) Effect of optogenetic inactivation, averaged from 8 mice. Laser stimulation significantly decreased NREM sleep (p < 0.0001, bootstrap) and increased
wakefulness (p < 0.0001).
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6 Cell 177, 1–15, May 16, 2019
Please cite this article in press as: Zhang et al., An Excitatory Circuit in the Perioculomotor Midbrain for Non-REM Sleep Control, Cell (2019),
https://doi.org/10.1016/j.cell.2019.03.041
Please cite this article in press as: Zhang et al., An Excitatory Circuit in the Perioculomotor Midbrain for Non-REM Sleep Control, Cell (2019),
https://doi.org/10.1016/j.cell.2019.03.041et al., 2011). Optogenetic activation of cholinergic neurons
(20 Hz, 2 min/trial) caused no significant change in any brain
state (p = 0.19, 0.09, and 0.09 for wake, NREM, and REM states,
respectively; Figure 4B). This was not due to ineffective activa-
tion of cholinergic neurons because, in a separate experiment,
we found that even a brief laser stimulation (20 Hz, 4 s/trial)
caused a strong reduction in pupil size (Figure 4D), likely
because of activation of preganglionic cholinergic neurons in
the Edinger-Westphal nucleus (Kozicz et al., 2011; McDougal
and Gamlin, 2015). Although these cholinergic neurons may
help to protect sleep from the awakening effect of visual stimu-
lation through pupil constriction (Yuzgec et al., 2018), their
optogenetic activation for a 2-min period appears to be insuffi-
cient to cause a significant increase in sleep. Conversely,
despite the strong sleep-promoting effect of the CALCA neuron
population (Figure 3), brief activation of these neurons had
little effect on pupil size (Figure 4D), suggesting that pupil
constriction requires the activation of some non-CALCA-
expressing cholinergic neurons.
We then tested the function of pIII glutamatergic neurons by
expressing ChR2 in Slc17a6Cre mice (Vong et al., 2011). Laser
stimulation of the glutamatergic neurons at a low power (1 mW
at the fiber tip) caused a strong increase in NREM sleep (p <
0.0001, bootstrap) and decreases in both wakefulness (p <
0.0001) and REM sleep (p < 0.0001; Figure 4C). Together with
the effect of cholinergic neuron activation (Figure 4B), this sug-
gests that the NREM-promoting effect of CALCA neurons is
mediated largely by the glutamatergic subpopulation. It is impor-
tant to note, however, that the effect of activation in Slc17a6Cre
mice is sensitive to the laser power; at high power (3–5 mW),
the stimulation increasedwakefulness and decreased sleep (Fig-
ure S4A). This is very different from the effect of laser stimulation
in CalcaCre mice, which promoted NREM sleep even at 10 mW
(Figure S4B); this may be because some of the non-CALCA-
expressing glutamatergic neurons outside of the pIII region pro-
mote wakefulness, and their activation at high laser power may
override the sleep-promoting effect of pIII NREM neurons.
CCK Neurons in the pIII Region Also Promote
NREM Sleep
Although the majority of pIII CALCA neurons are glutamatergic,
only a small fraction of glutamatergic neurons express CALCA
(Figure 4A). Our observation that glutamatergic neuron activation
at a low laser power enhancedNREMsleep (Figure 4C) raises the
possibility that, besides the CALCA-expressing subpopulation,
there are additional sleep-promoting glutamatergic neurons in
the pIII region. Fos immunohistochemistry in RS mice (which
labeled more sleep-active neurons than 4-OHT injection in the
FosCreER crossed with Cre-inducible EGFP-L10a mice) also
showed that only 36.7% ± 4.3% of Fos-expressing neurons
were CALCA cells (Figure S5A). Among the neuropeptides
known to be expressed in sleep-promoting neurons in other
brain regions (Chung et al., 2017), CCK is expressed in a(E) Chemogenetic activation experiment. Shown is the percentage of time in ea
hM3D(Gq). Horizontal axis, time after CNO/vehicle injection. Error bar, ± SEM; n
(F) Chemogenetic inactivation experiment in CalcaCre mice expressing hM4D(Gi)
See also Figure S3.population of pIII neurons. These CCK neurons are also glutama-
tergic but are distinct from the CALCA neurons (Figures 5A
and 5B), and FOS immunohistochemistry in RS mice showed
that 24.7% ± 1.8% of sleep-active neurons were CCK cells
(Figure S5A).
To test the functional role of the CCK neurons, we injected a
Cre-inducible AAV expressing ChR2 or iC++ into the pIII region
of CckCre mice (Taniguchi et al., 2011). Optogenetic activation
(20 Hz, 2 min/trial) of CCK neurons caused a significant increase
in NREM sleep (p < 0.0001, bootstrap) and decreases in both
wakefulness (p < 0.0001) and REM sleep (p < 0.0001; Figures
5C, S5B, and S5G) because of increases in both the initiation
and maintenance of NREM sleep (Figure S5D). In contrast, opto-
genetic inactivation of these neurons (constant light, 1 min/trial)
caused a significant decrease in NREM sleep and increase in
wakefulness (Figures 5D, S5C, and S5E). In control mice ex-
pressing eYFP only, laser stimulation had no effect (Figures
S5F), and the changes in brain states induced by laser stimula-
tion were significantly different between ChR2 and control
mice (p < 0.0001, bootstrap) and between iC++ and control
mice (p < 0.0001). Thus, the CCK-expressing glutamatergic
neurons in the pIII region also promote NREM sleep.
Reciprocal Connections between CCK and CALCA
Neurons
Given the spatial proximity between CCK and CALCA neurons,
both of which promote NREM sleep, we wondered whether
they interact with each other through local synaptic connections.
To detect local inputs to CALCA neurons, we expressed an avian
retroviral receptor (TVA) fused with mCherry (TC66T) (Miyamichi
et al., 2013) and a rabies glycoprotein (RG) by injecting two
Cre-inducible AAV vectors (AAV2-CAG-FLEx-TC66T and AAV2-
CAG-FLEx-RG) into the pIII region of CalcaCre mice. A modified
rabies virus (RV) expressing EGFP (RVdG-EGFP+EnvA) was
injected 3 weeks later to infect the TC66T-expressing target neu-
rons and to label their presynaptic inputs (Wickersham et al.,
2007). Among the EGFP-labeled neurons in the pIII region,
many expressed CCK (Figure 6A), indicating direct CCK /
CALCA neuron connections. Conversely, the tracing experiment
performed inCckCremice revealed direct CALCA/CCK neuron
connections (Figure 6B). In control mice injected with AAV-CAG-
FLEx-TC66T and RV without AAV-CAG-FLEx-RG, we found no
presynaptic neurons expressing EGFP without mCherry (Figures
S6A and S6B), indicating specificity of transsynaptic RV labeling.
In addition to RV-mediated anatomical tracing, we also
measured functional connections between CALCA and CCK
neurons using electrophysiological recordings in acute brain
slices. To measure CCK / CALCA neuron input, we injected
AAV-DIO-ChR2-eYFP into the pIII region of CckCre mice.
Whole-cell recordings were made in non-ChR2-expressing neu-
rons, and cell types were identified using single-cell RT-PCR
(Xu et al., 2015). As shown in Figures 6C and 6D, laser stimulation
evoked excitatory postsynaptic potentials (EPSPs) in 11 ofch brain state following CNO or vehicle injection in CalcaCre mice expressing
= 5 mice. *p < 0.05, ***p < 0.001 (two-way ANOVA with Bonferroni correction).
. n = 5 mice.
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Figure 4. Glutamatergic but Not Cholinergic pIII Neurons Promote NREM Sleep
(A) Overlap between Calca and Slc17a6 (top row) or Chat (bottom row) in the pIII region, measured by double FISH. Shown are coronal images at AP 3.8 mm.
Arrowheads indicate co-labeled cells. Blue, DAPI. Scale bar, 100 mm. Right: percentages of Calca, Slc17a6, or Chat neurons that are co-labeled. Each circle
indicates data from one mouse (n = 5 mice).
(B) Optogenetic activation of cholinergic pIII neurons did not affect sleep. Left: fluorescence image of the pIII region (red box in the coronal diagram at AP
3.8 mm) in a ChatCre mouse injected with AAV-EF1a-DIO-hChR2-eYFP. Blue, DAPI. Scale bar, 100 mm. Right: percentage of time in the NREM, REM, or wake
state before, during, and after laser stimulation, averaged from 4 mice. Shading, 95% CI. Blue stripe, laser stimulation period (20 Hz, 120 s).
(legend continued on next page)
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Figure 5. CCK Neurons in the pIII Region Promote NREM Sleep
(A) CCK and CALCA neurons are distinct populations in the pIII region. Left: fluorescence image showing double FISH of Calca and Cck in the pIII region (red box
in the coronal diagram at AP3.8 mm). Blue, DAPI. Scale bar, 100 mm. Right: number of neurons expressing Calca,Cck, or both. Each circle indicates data from
one mouse (n = 5 mice).
(B) CCK neurons are glutamatergic. Left: double FISH of Cck and Slc17a6 in the pIII region (red box in the coronal diagram at AP 3.8 mm). Scale bar, 100 mm.
Right: percentage of Cck- or Slc17a6-expressing neurons that are co-labeled. Each circle indicates data from one mouse (n = 6 mice).
(C) Optogenetic activation of CCK neurons promotes NREM sleep. Left: fluorescence image of the pIII region (red box in the coronal diagram at AP3.8 mm) in a
CckCremouse injected with AAV-EF1a-DIO-hChR2-eYFP. Scale bar, 100 mm. Right: percentage of time in the NREM, REM, or wake state before, during, and after
laser stimulation, averaged from 8 mice. Shading, 95% CI. Blue stripe, laser stimulation period (20 Hz, 120 s). Laser stimulation significantly increased NREM
sleep (p < 0.0001, bootstrap) and decreased wakefulness (p < 0.0001) and REM sleep (p < 0.0001).
(D) Similar to (C) but for optogenetic inactivation of CCK neurons (n = 6 mice). Laser stimulation significantly decreased NREM sleep (p < 0.0001, bootstrap) and
increased wakefulness (p < 0.0001). Blue stripe, laser stimulation period (constant illumination, 60 s).
See also Figure S5.
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https://doi.org/10.1016/j.cell.2019.03.04115 glutamatergic CALCA neurons, which were blocked by the
a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
receptor antagonist cyanquixaline (CNQX), confirming functional
CCK/ CALCA neuron excitation. Conversely, in CalcaCre mice
injected with AAV-DIO-ChR2-eYFP, laser stimulation evoked
glutamatergic EPSPs in 7 of 12 CCK neurons (Figures 6E
and 6F), demonstrating CALCA/ CCK neuron excitation.
Together, these anatomical and electrophysiological experi-
ments indicate that CCK- and CALCA-expressing neurons are
reciprocally connected within the pIII region. Reciprocal excita-
tion between neuronal populations could serve to reinforce and
stabilize their activation, making the activity pattern resistant to
small perturbations or noise (Wang, 2009). Because both CCK(C) Similar to (B) but in Slc17a6Cremice (n = 6 mice). Shown is a coronal image at A
bootstrap) and decreased wakefulness (p < 0.0001) and REM sleep (p < 0.0001)
(D) Optogenetic activation of cholinergic (top) but not CALCA-expressing (botto
normalized by its mean over the 2 s before laser stimulation. Shading, ± SEM. B
See also Figure S4.and CALCA pIII neurons promote NREM sleep, the reciprocal
excitation between them could contribute to the stability of
NREM sleep.
Long-Range Projections of CALCA and CCK Neurons
Finally, we examined the long-range projections of CALCA and
CCK neurons. Both populations of pIII neurons project rostrally
and arborize extensively in the POA, a prominent sleep-promot-
ing brain area (von Economo, 1930; Lu et al., 2000; McGinty and
Sterman, 1968; Nauta, 1946; Sallanon et al., 1989; Zhang et al.,
2015). To test the functional role of the POA projection from CCK
neurons, we injected AAV-DIO-ChR2-eYFP into the pIII region of
CckCre mice and inserted an optic fiber into the POA. ActivationP3.7 mm. Laser stimulation significantly increased NREM sleep (p < 0.0001,
.
m) pIII neurons caused pupil constriction. For each trial, the pupil area was
lue stripe, laser stimulation period (20 Hz, 4 s).
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Figure 6. CCK and CALCA Neurons Form Reciprocal Connections
(A) Monosynaptic innervation of CALCA neurons by CCK neurons. Left: fluorescence image (at AP 3.8 mm) of starter cells in the pIII region (expressing both
EGFP and mCherry, indicated by arrowheads). Right: fluorescence image (at AP 3.8 mm) of double FISH of EGFP and Cck. The regions in the white boxes are
shown on the right. Arrowheads indicate co-labeled neurons. Blue, DAPI. Scale bars, 100 mm.
(B) Similar to (A) for innervation of CCK neurons by CALCA neurons. The coronal images are at AP 3.9 mm (left) and 3.8 mm (right).
(C) CCK / CALCA neuron connections measured electrophysiologically. Left: schematic of slice recording. Center, light-evoked excitatory postsynaptic
potential (EPSP) in an example CALCA neuron (red, recorded under current clamp), which was blocked by CNQX (20 mM, black). Blue tick, laser stimulus. Right:
single-cell RT-PCR identification of the recorded CALCA neuron, which also expressed Slc17a6.
(D) Population summary of EPSP amplitude and latency. Red circles, cells with significant responses (p < 0.05, t test). Gray circles, cells with no significant
response. Bar, mean ± SEM.
(E and F) Similar to (C) and (D) for CALCA/ CCK neuron connections.
See also Figure S6.
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Figure 7. Rostral and Caudal Projections of pIII Neurons Promote NREM Sleep
(A) Optogenetic activation of CCK neuron axons in the POA promotes NREM sleep. Left: fluorescence image of POA (red box in the coronal diagram) in a CckCre
mouse injected with AAV-DIO-ChR2-eYFP into the pIII. Blue, DAPI. POA, preoptic area; aca, anterior commissure. Scale bar, 100 mm. Right: percentage of time in
the NREM, REM, or wake state before, during, and after laser stimulation, averaged from 5 mice. Shading, 95% CI. Blue stripe, laser stimulation period (20 Hz,
120 s). Laser stimulation significantly increased NREM sleep (p < 0.0001, bootstrap) and decreased wakefulness (p < 0.0001) and REM sleep (p < 0.0001).
(B) Similar to (A) for optogenetic activation of CALCA neuron axons in the POA (n = 5 mice). Laser stimulation significantly increased NREM sleep (p < 0.0001,
bootstrap) and decreased wakefulness (p < 0.0001).
(C) Similar to (A) for optogenetic activation of glutamatergic neuron axons in the POA of Slc17a6Cre mice (n = 5 mice). Laser stimulation significantly increased
NREM sleep (p < 0.0001, bootstrap) and decreased wakefulness (p < 0.0001) and REM sleep (p < 0.0001).
(D) Fluorescence image of the posterior ventromedial medulla (red box in coronal diagram) in aCckCremouse injectedwith AAV-DIO-ChR2-eYFP in the pIII region,
showing no projection from CCK neurons to the posterior ventromedial medulla. py, pyramidal tract. GiV, gigantocellular reticular nucleus.
(E) Optogenetic activation of CALCA neuron axons in the posterior ventromedial medulla; n = 5 mice. Laser stimulation significantly increased NREM sleep
(p < 0.0001, bootstrap) and decreased wakefulness (p < 0.0001).
(F) Similar to (E) for optogenetic activation of glutamatergic neuron axons in the posterior ventromedial medulla; n = 5 mice. Laser stimulation significantly
increased NREM sleep (p < 0.0001, bootstrap) and decreased wakefulness (p < 0.0001) and REM sleep (p < 0.0001).
See also Figure S7.
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both wakefulness and REM sleep (Figure 7A; p < 0.0001). Other
than the POA, themain projection targets of pIII CCK neurons arethe lateral hypothalamus (LH) and lateral septum (LS) (Fig-
ure S7A). However, laser stimulation had no significant effect in
either the LH (p = 0.38, 0.37, and 0.21 for wake, NREM, andCell 177, 1–15, May 16, 2019 11
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indicating that the POA projection is particularly important for
sleep regulation by pIII CCK neurons.
Activation of CALCA neuron axons in the POA also caused a
strong increase in NREM sleep and decrease in wakefulness
(Figure 7B; p < 0.0001, bootstrap). Similar effects were induced
by activating the POA projection in Slc17a6Cre mice (Figure 7C).
In contrast, we found no POA projection from cholinergic or gal-
aninergic pIII neurons (Figures S7C and S7D), indicating that the
effect of activating CALCA neuron axons (Figure 7B) is caused by
the glutamatergic subset. Optogenetic stimulation of axon termi-
nals could, in principle, evoke antidromic spiking and activation
of other collateral projections. We thus tested the effect of local
chemogenetic activation, which causes slow depolarization of
axon terminals through G protein-coupled signaling and is un-
likely to induce antidromic spiking (Forcelli, 2017). In CalcaCre
mice injected with AAV-DIO-hM3D(Gq)-mCherry in the pIII re-
gion, local CNO injection in the POA caused a significant in-
crease in NREM sleep (Figure S7E), further demonstrating a
contribution of the POA projection to sleep regulation.
CALCA but not CCK neurons also project caudally, arborizing
extensively in the posterior ventromedial medulla (Figures 7D
and 7E). Activating the CALCA neuron axons in this region also
increased NREM sleep and decreased wakefulness (Figure 7E;
p < 0.0001). Similar effects were observed by activating the pIII
/ medulla projection in Slc17a6Cre mice (Figure 7F). Interest-
ingly, dual retrograde tracing showed that the pIII glutamatergic
neurons projecting to the ventromedial medulla and the POA are
largely separate populations (Figure S7G), indicating that, even
with antidromic spiking, the NREM increase induced by medulla
stimulation is unlikely mediated by the POA projection and vice
versa. Local chemogenetic activation of CALCA neuron termi-
nals in the medulla also caused a significant increase in NREM
sleep (Figure S7F), further supporting the contribution of this pro-
jection. In addition to the POA and medulla, pIII CALCA neurons
also project to the medial vestibular nucleus (MV) and LH (Fig-
ure S7B). Optogenetic stimulation of CALCA neuron terminals
in the MV had no significant effect (p = 0.18, 0.15, and 0.48 for
wake, NREM, and REM states, respectively). Although stimula-
tion in the LH caused an increase in NREM sleep (p = 0.006),
the magnitude of the increase was significantly lower than those
induced by POA (p < 0.0001, bootstrap) or medulla (p < 0.0001)
stimulation. Together, these results indicate that the POA and
medulla projections from pIII CALCA neurons are particularly
important for NREM sleep generation.
DISCUSSION
Using activity-dependent labeling, gene profiling, optrode
recording, and bidirectional optogenetic and chemogenetic
manipulations, we identified two interconnected populations of
excitatory sleep neurons in the midbrain. Although the CCK-
expressing population is almost entirely glutamatergic (Fig-
ure 5B), the CALCA population contains both glutamatergic
and cholinergic neurons (Figure 4A). The NREM-promoting ef-
fect, however, is at least partly attributable to the glutamatergic
subpopulation (Figures 4B and 4C). In addition to their reciprocal
connections within the pIII region (Figure 6), both CALCA and12 Cell 177, 1–15, May 16, 2019CCK neurons send long-range projections to other brain regions,
including the well-known sleep-promoting area POA. Activation
of both the rostral and caudal projections promoted NREM sleep
(Figure 7), indicating multiple downstream pathways mediating
the effect.
Cholinergic neurons in the Edinger-Westphal nucleus in the
pIII region are known to control pupil constriction through their
projection to the parasympathetic ciliary ganglion (Kozicz
et al., 2011; McDougal and Gamlin, 2015; Yuzgec et al., 2018).
The pupil size is tightly coupled to the animal’s brain state, and
it is greatly reduced during drowsiness and sleep (McGinley
et al., 2015; Reimer et al., 2014, 2016; Vinck et al., 2015; Yuzgec
et al., 2018). This implies that preganglionic cholinergic neurons
are active during sleep and that they may correspond to the
EGFP-labeled cholinergic population in RS mice (Figure 1C).
These cholinergic neurons may share common inputs with
sleep-active glutamatergic neurons or even receive input from
the glutamatergic population. The pupil constriction caused by
their activation could, in turn, contribute to sleep stabilization
by gating visual inputs (Yuzgec et al., 2018). It is interesting to
note that Mauthner originally proposed the pIII region as a sleep
center partly because of the oculomotor changes associated
with natural sleep. In future studies, it would be of great interest
to characterize the interactions between neurons controlling
sleep versus oculomotor functions.
Given the effects of CALCA neuron activation (Figure 3), the
NREM-promoting effect of CCK neurons could be partly medi-
ated by the CCK / CALCA connection (Figures 6A and 6C).
Conversely, the NREM-promoting function of CALCA neurons
could be partlymediatedby theCALCA/CCKpathway (Figures
6B and 6D). These reciprocal connections could serve to stabilize
the activation of both populations during sleep. Both CALCA and
CCK neurons project to the POA (Figures 7A and 7B), which con-
tains a large number of GABAergic sleep-active neurons (Chung
et al., 2017;Gong et al., 2004;McGinty andSterman, 1968; Sherin
et al., 1996; Takahashi et al., 2009; Zhang et al., 2015). The sleep-
promoting effect of pIII glutamatergic neurons is likely to involve
their excitation of POA sleep neurons. The caudal projection of
CALCA neurons to the posterior ventromedial medulla promotes
NREM sleep as well (Figure 7E), although the downstream target
neuronsmediating the effect remain to be identified. In RSandSD
mice, there were similar numbers of EGFP-labeled neurons in this
region (Figure S1A; Table S1), suggesting intermingled sleep- and
wake-active neurons. Besides the CALCA and CCK populations,
there may be additional NREM-promoting glutamatergic neurons
in the midbrain. The recurrent local connections among these
neurons could help to stabilize their activation during sleep,
whereas the divergent long-range projections may serve to coor-
dinate the global transition fromwakefulness to sleep acrossmul-
tiple brain regions.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
FosCreER, Gt(ROSA)26SorEGFP/Rpl10a, ChatCre, Slc17a6Cre and CckCre (Jackson stock no: 021882, 024750, 006410, 016963, and
012706 respectively) were obtained from Jackson Laboratory. GalCre (stock no: 031060-UCD) was obtained from GENSAT. A new
line of CalcaCre:GFP mice (version 2) was generated by replacing the Cre:GFP cassette in the original line (Carter et al., 2013) with
a cassette containing an attenuated Cre recombinase; the nuclear localization signal was removed, the Kozak initiation codon
was not optimal and the 30 untranslated region was replaced with one from the Myc gene to destabilize the mRNA. These mice
were using hybrid G4 ES cells (C57BL/6 3 129/Sv) and then backcrossed onto a C57BL/6 background for multiple generations.
Micewere housed in 12 hr light-dark cycle (lights on at 07:00 am and off at 07:00 pm) with free access to food andwater. Experiments
were performed in adult male or female mice (2-6 months old). All procedures were approved by the Animal Care and Use Commit-
tees of the University of California, Berkeley.Cell 177, 1–15.e1–e6, May 16, 2019 e2
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Virus Preparation
AAV2-EF1a-DIO-ChR2-eYFP, AAV2-EF1a-DIO-iC++-eYFP, AAV2-EF1a-DIO-eYFP, AAV2-EF1a-DIO-hM3D(Gq)-mCherry, AAV2-
EF1a-DIO-hM4D(Gi)-mCherry, AAV2-EF1a-DIO-mCherry, and AAV2-EF1a-DIO-taCasp3-TEVp were obtained from the University
of North Carolina (UNC) vector core. AAV2-CAG-FLEx-TC66T (Addgene; plasmid #48331), AAV2-CAG-FLEx-RG (RG, rabies
glycoprotein; Addgene; plasmid #74292), rAAV2-retro-EF1a-DIO-mCherry and rAAV2-retro-EF1a-DIO-eGFP (Tervo et al., 2016)
were prepared in house according to previously described protocols (Hauswirth et al., 2000; Zhang et al., 2016). RG-deleted,
eGFP-expressing rabies virus (RVdG) was purchased from Gene Transfer Targeting and Therapeutics Core of Salk Institute, ampli-
fied in B7GG cells, pseudotyped with BHK-EnvA cells, and titered with HEK293-TVA cells (Osakada and Callaway, 2013).
Surgical Procedures
Adult mice (6-12 weeks old) were anesthetized with 1.5%–2% isoflurane and placed on a stereotaxic frame. Body temperature was
kept stable throughout the procedure using a heating pad. After asepsis, the skin was incised to expose the skull, and the overlying
connective tissue was removed. For EEG and EMG recordings, a reference screw was inserted into the skull on top of the left
cerebellum. EEG recordings were made from two screws on top of the left and right cortex, at anteroposterior (AP) –3.5 mm, medio-
lateral (ML) 3 mm and AP +1.5 mm, ML 1.5 mm, respectively. Two EMG electrodes were inserted into the neck musculature.
Insulated leads from the EEG and EMG electrodes were soldered to a pin header, which was secured to the skull using dental
cement. Mice of specific genotype were randomly assigned to experimental and control groups. Experimental and control animals
were subjected to exactly the same surgical and behavioral manipulations. Investigators were not blinded to animal identity and
outcome assessment.
For optogenetic activation/inactivation experiments, a craniotomy (0.5-1mm diameter) was made on top of the target regions
(see below for coordinates), and 0.1-0.3 ml virus was injected into the target regions using Nanoject II (Drummond Scientific)
via a micro pipette. Optic fibers (0.2 mm diameter; Thorlabs) were implanted into the target region with the tip 0.2 mm above
the virus injection site two weeks after viral injection. Dental cement was applied to cover the exposed skull completely and
to secure the implants for EEG and EMG recordings to the screws. Data from all CalcaCre and Cck-Cre mice were included.
For optogenetic experiment in Slc17a6Cre mice, data from 3 mice were excluded, because the tips of the optic fibers
were in the dorsal periaqueductal gray. For chemogenetic experiments, 0.2 ml AAV2-EF1a-DIO-hM3D(Gq)-mCherry or
AAV2-EF1a-DIO-hM4D(Gi)-mCherry was injected into the target region. After surgery, mice were allowed to recover for at least
2 weeks before experiments.
For optrode recording experiments, a custom-made optrode assembly was inserted into the pIII region. The optrode assembly was
secured to the skull together with EEG and EMG electrodes using dental cement.
For rabies-mediated retrograde transsynaptic tracing, 0.3 ml of mixed AAV2-CAG-FLEx-TC66T and AAV2-CAG-FLEx-RG was
injected into the target region of the corresponding Cre mice. Three weeks later, RVdG pseudotyped with EnvA was injected into
the same region, and mice were sacrificed 5-6 days later for histology.
Stereotaxic coordinates for virus injection and optic fiber implantation:
pIII region: anteroposterior (AP) 3.8 mm, mediolateral (ML) 0 mm, dorsoventral (DV) 3.5 mm
Posterior ventromedial medulla: AP 6.9 mm, ML 0 mm, DV 5.7 mm
POA: AP 0 mm, ML 0.7 mm, DV 5.2 mm (unilateral)
LH: AP 1.8 mm, ML 1.5 mm, DV 5.0 mm (unilateral)
LS: AP 0.3 mm, ML 0.5 mm, DV 2.5 mm (unilateral)
MV: AP 6.0 mm, ML 0.5 mm, DV 3.8 mm (unilateral)Polysomnographic Recordings
Behavioral experiments were carried out in home cages placed in sound-attenuating boxes between 9:00 am and 7:00 pm. EEG and
EMG electrodes were connected to flexible recording cables via amini-connector. Recordings started after 20-30min of habituation.
The signals were recorded with a TDT RZ5 amplifier (bandpass filter, 1-750 Hz; sampling rate, 1,500 Hz). Spectral analysis was car-
ried out using fast Fourier transform (FFT), and brain states were classified into NREM, REM and wake states (wake: desynchronized
EEG and high EMG activity, NREM: synchronized EEG with high-amplitude, low-frequency (0.5-4 Hz) activity and low EMG activity,
REM: high power at theta frequencies (6-9 Hz) and low EMG activity). The classification was made using a custom-written graphical
user interface (programmed in MATLAB, MathWorks).
Sleep Deprivation and Sleep Rebound Experiment
Sleep deprivation started at the beginning of the light period (7 am). Mice were kept awake by introducing novel objects or tapping
lightly on the cages. To reduce the possibility of stress,micewere never touched directly. After 5 or 6 hr of deprivation, sleep-deprived
mice were allowed rebound sleep in their home cages.e3 Cell 177, 1–15.e1–e6, May 16, 2019
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Custom-made optrodes consisted of an optic fiber (200 mm in diameter) glued together with 6 pairs of stereotrodes. Two FeNiCr wires
(Stablohm 675, California Fine Wire) were twisted together and electroplated to an impedance of 200 kU using a custom-built
plating device. The optrode was attached to a driver to allow vertical movement of the optrode assembly. Wires to record cortical
EEG and EMG from neck musculatures were also attached for simultaneous recordings. A TDT RZ5 amplifier was used for all the
recordings, signals were filtered (0.3-8 kHz) and digitized at 25 kHz. At the end of the experiment, an electrolytic lesion was made
by passing a current (100 mA, 10 s) through one or two electrodes to identify the end of the recording tract.
Spikes were sorted offline based on the waveform energy and the first three principal components of the spike waveform on each
stereotrode channel. Single units were identified automatically using the software KlustaKwik (http://klustakwik.sourceforge.net).
The quality of each unit was assessed by the presence of a refractory period and quantified using isolation distance and L-ratio. Units
with an isolation distance < 20 and L-ratio > 0.1 were discarded.
To identify ChR2-tagged neurons, laser pulse trains (15 and 30 Hz with duration of 1 and 0.5 s, respectively) were delivered every
1 or 2 min. A unit was identified as ChR2 expressing if spikes were evoked by laser pulses with high reliability (> 0.7 for all units in our
sample), short first-spike latency (< 3ms for all units in our sample), low jitter (< 2 ms for all units in our sample), and the waveforms of
the laser-evoked and spontaneous spikes were highly similar (correlation coefficient > 0.9). To calculate the average firing rate of
each unit in each brain state, spikes during the laser pulse trains were excluded.
Optogenetic Manipulation
Each optic fiber was attached through an FC/PC adaptor to a 473-nm blue laser diode (Shanghai laser), and light pulses were gener-
ated using the TDT system. For all optogenetic activation experiments, each trial consisted of a 20 Hz pulse train (10 ms per pulse)
lasting for 120 s. For optogenetic inactivation (60 s), constant light was used. For most experiments, the laser power was 4-6 mW at
fiber tip. InSlc17a6Cremice, the effects of optogenetic activation were different between low (1mW) and high (3-5mW) laser power. In
CalcaCre andCckCremice we have also tested the effects of laser at 10mW (Figures S4B and S5G). In each optogenetic manipulation
experiment, inter-trial interval was chosen randomly from a uniform distribution between 10 and 14 min, regardless of which brain
state the animal is in. Each experimental session lasted for 3 hr, and each animal was tested in 6-8 sessions.
Chemogenetic Manipulation
Saline (0.9% NaCl) or CNO dissolved in saline was injected intraperitoneally (i.p.) into the corresponding Cre mice expressing
hM3D(Gq) or hM4D(Gi) in the target region. CNO dose was 1 mg/kg body weight for activation (in Gq-expressing mice) and
5 mg/kg body weight for inactivation (in Gi-expressing mice). For the control experiment (in mCherry-expressing mice), CNO
(5 mg/kg) or saline was administered. Each recording session started immediately after injection. In each test set, mice were
administered with saline on the first day and CNO on the second day. Each mouse was subjected to 3-4 test sets, and the data
were averaged across all sets. For local chemogenetic activation of CALCA neuron axons, a guide cannula was inserted into the
POA or posterior ventromedial medulla. CNO (3 mM, 50 – 100 nL) was intracranially microinjected into the target region.
Pupillometry
The pupil wasmonitored with an infrared video camera at 30 Hz sampling rate. Video files were loaded into MATLAB, and each frame
was converted to a binary image. The pupil was fitted with an ellipse using a custom-written MATLAB program to measure its area.
For each session, the pupil size was normalized by the mean value during the 2 s preceding the laser stimulation.
Slice Recording
AAVDJ-EF1a-DIO-ChR2-eYFP (500 nl) was injected into the pIII ofCckCre orCalcaCremice, and recording wasmade 2-4 weeks after
injection. Slice preparation was according to procedures described previously (Xu et al., 2015). Briefly, mouse was deeply anaesthe-
tized with 5% isoflurane. After decapitation, the brain was dissected rapidly and placed in ice-cold oxygenated HEPES buffered
artificial cerebrospinal fluid (ACSF; in mM: NaCl 92, KCl 2.5, NaH2PO4 1.2, NaHCO3 30, HEPES 20, glucose 25, sodium ascorbate
5, thiourea 2, sodium pyruvate 3, MgSO4$7H2O 10, CaCl2$2H2O 0.5 and NAC 12, at pH 7.4, adjusted with 10 M NaOH), and coronal
sections of the pIII were made with a vibratome (Leica). Slices (300 mm thick) were recovered in oxygenated NMDG-HEPES solution
(in mM: NMDG 93, KCl 2.5, NaH2PO4 1.2, NaHCO3 30, HEPES 20, glucose 25, sodium ascorbate 5, thiourea 2, sodium pyruvate 3,
MgSO4$7H2O 10, CaCl2$2H2O 0.5 and NAC 12, at pH 7.4, adjusted with HCl) at 32
C for 10 min and thenmaintained in an incubation
chamber with oxygenated standard ACSF (in mM: NaCl 125, KCl 3, CaCl2 2, MgSO4 2, NaH2PO4 1.25, sodium ascorbate 1.3, sodium
pyruvate 0.6, NaHCO326, glucose 10 and NAC 10, at pH 7.4, adjusted by 10 M NaOH) at 25
C for 1-4 h before recording. All
chemicals were from Sigma.
Whole-cell recordings were made at 30 C in oxygenated solution (in mM: NaCl 125, KCl 4, CaCl2 2, MgSO4 1, NaH2PO4 1.25,
sodium ascorbate 1.3, sodium pyruvate 0.6, NaHCO3 26, and glucose 10). Excitatory postsynaptic potentials (EPSPs) were recorded
using a potassium-based internal solution (inmM: potassium gluconate 135, KCl 5, HEPES 10, EGTA 0.3, MgATP 4, Na2GTP 0.3, and
sodium phosphocreatine 10, at pH 7.3, 290-300mOsm) in the presence of GABAA receptor antagonist bicuculline (20 mM). The resis-
tance of the patch pipette was 3-5 MU. The cells were excluded if the series resistance exceeded 40 MU or varied bymore than 20%
during the recording period. To activate ChR2, we used a mercury arc lamp (Olympus) coupled to the epifluorescence light path andCell 177, 1–15.e1–e6, May 16, 2019 e4
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through a 403 0.8 numerical aperture water immersion lens (Olympus) at a power of 1-2 mW. Data were recorded with a Multiclamp
700B amplifier (Axon instruments) filtered at 2 kHz and digitized with a Digidata 1440A (Axon instruments) at 4 kHz. Recordings were
analyzed using Clampfit (Axon instruments).
Single-Cell RT-PCR
At the end of each recording, cytoplasmwas aspirated into the patch pipette, expelled into a PCR tube as described previously (Lam-
bolez et al., 1992). The single cell RT-PCR protocol was designed to detect the presence of mRNAs coding forGad1, Slc17a6, Chat,
Calca, Cck and Gal. First, reverse transcription and the first round of PCR amplification were performed with gene-specific multiplex
primer using the SuperScript III One-Step RT-PCR kit (12574-018, Invitrogen) according to the manufacturer’s protocol. Second,
nested PCR was carried out using AmpliTaq Gold 360 PCR kit (4398886, Invitrogen) with nested primers for each gene. All multiplex
primers were designed to target two different exons to differentiate mRNAs from genomic DNA. The final PCR products were
sequenced and verified. Amplification products were visualized via electrophoresis using 2% agarose gel.
Primers (50 > 30) for single-cell RT-PCR:
Gad1 (sense/anti-sense):
multiplex, cacaggtcaccctcgatttt/tctatgccgctgagtttgtg;
nested, tagctggtgaatggctgaca/cttgtaacgagcagccatga
Final product 200 bp
Slc17a6 (sense/anti-sense):
multiplex, gccgctacatcatagccatc/gctctctccaatgctctcctc;
nested, acatggtcaacaacagcactatc/ataagacaccagaagccagaaca
Final product 506 bp
Calca (sense/anti-sense):
multiplex, CCTGAAGTTCTCCCCTTTCCT /GAGGTCTTGTGTGTACGTGC;
nested, ATGCAGATGAAAGCCAGGGA/TACTCAGATTCCCACACCGC
Final product 100bp
Cck (sense/anti-sense):
multiplex, TGTCTGTGCGTGGTGATGGC/ GCATAGCAACATTAGGTCTGGGAG;
nested, ATACATCCAGCAGGTCCGCAA/ CAGACATTAGAGGCGAGGGGT
Final product 237 bp
Chat (sense/anti-sense):
multiplex,
ATGGCCATTGACAACCATCTTCTG/CCTTGAACTGCAGAGGTCTCTCAT;
nested, same as multiplex.
Final product 324 bp
Gal (sense/anti-sense):
multiplex, AGCCTTGATCCTGCACTGAC/ TGCACAGTGGACATGGTCTC;
nested, AACCACAGATCATTTAGCGACAA/ CCCGGCCTCTTTAAGGTGC
Final product 286 bpImmunohistochemistry and Fluorescence in situ Hybridization (FISH)
Mice were deeply anaesthetized and transcardially perfused with 0.1M PBS followed by 4% paraformaldehyde (w/v) in PBS. For
fixation, brains were kept overnight in 4% paraformaldehyde. For cryoprotection, brains were placed in 30% sucrose (w/v) in PBS
solution for 36-48 hr. After embedding and freezing, brains were sectioned into 20 (for FISH and a subset of immunohistochemistry)
or 50-mm (for other immunohistochemistry) coronal slices using a cryostat. For immunohistochemistry, brain slices were washed
using PBS three times, permeabilized using PBST (0.3% Triton X-100 in PBS) for 30 min and then incubated with blocking solution
(5% normal goat serum or normal donkey serum in PBST) for 1 hr followed by primary antibody incubation overnight at 4C using
anti-GFP (GFP-1020, Aves Labs, 1:500) and anti-cFos (sc-52, Santa Cruz biotech, 1:500) antibodies. The next day, slices were
washed with PBS and incubated with appropriate secondary antibodies for 2 hr (1:1000, All from Invitrogen): A-11039, Alexa Fluor
488 goat anti-chicken IgG and A-11012, Alexa Fluor 594 goat anti-rabbit IgG. FISH was done using RNAscope Multiplex Fluorescent
Assays V2 according to the manufacturer’s instructions (Advanced Cell Diagnostics). Fluorescence images were taken using a
fluorescence microscope (Keyence BZ-X710), a confocal microscope (LSM 710 AxioObserver Inverted 34-Channel Confocal, Zeiss)
and Nanozoomer.e5 Cell 177, 1–15.e1–e6, May 16, 2019
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TRAP experiment was performed as previously described (Heiman et al., 2014; Knight et al., 2012; Nectow et al., 2015). Briefly, mice
were sacrificed and the pIII region was rapidly dissected on ice with a dissection buffer (1x HBSS, 2.5 mM HEPES [pH 7.4], 4 mM
NaHCO3, 35 mM glucose, 100 mg/ml cycloheximide). Tissues from 7-8 mice were then pooled, homogenized in the homogenization
buffer (20 mM HEPES [pH 7.4], 150 mM KCl, 10 mMMgCl2, 0.5 mM DTT, 80 U/ml RNasin, 40 U/ml Superasin, 100 mg/ml cyclohex-
imide and protease). Homogenates were transferred to a microcentrifuge tube and clarified at 2,000xg for 10 min at 4C. The
supernatant was transferred to a new tube, and 1/9 sample volume of 10% NP40 and 1/9 sample volume of 1,2-diheptanoyl-sn-
glycero-3-phosphocholine (DHPC, 300mM) were added to the supernatant. This solution was mixed and then clarified at
20,000xg for 10 min at 4C. The resulting supernatant was transferred to a new tube. This supernatant served as the input. A small
amount (50 ml) was taken and added to a new tube containing 100 mL of lysis buffer from Absolutely RNA Nanoprep kit (Agilent) for
future input RNA purification. The rest of the supernatant were used for immunoprecipitation with eGFP antibodies (Memorial-Sloan
Kettering Monoclonal Antibody Facility; clone names: Htz-GFP-19F7 and Htz-GFP-19C8, bioreactor supernatant purity).
Immunoprecipitation was performed with an anti-eGFP antibody loaded biotinylated Protein L magnetic Dynabeads. The samples
and beads were incubated for 1h at 4C. The beads were washed four times using 0.35M KCI wash buffer (20 mM HEPES [pH 7.4],
350mMKCl, 10mMMgCl2, 0.5mMDTT, 1%NP40, 40U/ml RNasin, and 100 mg/ml cycloheximide). After the final wash the RNAwas
eluted by addition of lysis buffer (100 mL) to the beads. Beads were removed with a magnet. Both the input and IP RNAs are purified
with Absolutely RNANanoprep kit (Agilent) and analyzed with an Agilent 2100 Bioanalyzer. cDNAswere generated and amplified with
SMART-Seq v4 Ultra Low Input RNA Kit. cDNA libraries for RNA-seq were prepared with Illumina Nextera Library Prep Kit and
analyzed on an Illumina HiSeq 2500. RNA-Seq data were analyzed with RSEM (RNA-Seq by Expectation-Maximization)(Li and
Dewey, 2011). Transcripts with TPM (Transcripts Per Kilobase Million) > 1 were used for analysis.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was performed using MATLAB and SigmaPlot. All statistical tests were two-sided. The 95% confidence intervals
(CI) for brain state probabilities were calculated using a bootstrap procedure: For an experimental group of n mice, with mouse
i comprising mi trials, we repeatedly resampled the data by randomly drawing for each mouse mi trials (random sampling with
replacement). For each of the 10,000 iterations, we recalculated the mean probabilities for each brain state across the n mice.
The lower and upper confidence intervals were then extracted from the distribution of the resampled mean values. To test whether
a given brain state is significantly modulated by laser stimulation, we calculated for each bootstrap iteration the difference between
the mean probabilities during laser stimulation and the preceding period of identical duration. The ‘‘n’’ number for each experiment is
provided in the text and figure legends.
DATA AND SOFTWARE AVAILABILITY
Data Resources
The accession number for the raw and analyzed data files for the TRAP sequencing analysis reported in this paper is NCBI Gene
Expression Omnibus: GSE124681.Cell 177, 1–15.e1–e6, May 16, 2019 e6
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Figure S1. Quantification and Control Experiments for Activity-Dependent Genetic Labeling, Related to Figure 1
(A) Ratio between eGFP-labeled neurons in recovery sleep (RS) and sleep deprivation (SD) mice in multiple brain regions involved in sleep-wake regulation.
Error bar, SEM; n = 5 pairs of littermates. pIII, perioculomotor region; PZ, parafacial zone; DPGi/LPGi, dorsal/lateral paragigantocellular nucleus; LPO, lateral
preoptic area; NST, nucleus of the solitary tract; SCN, suprachiasmatic nucleus; DMH/VMH, dorsomedial/ventromedial hypothalamic nucleus; BNST, bed
nucleus of the stria terminalis; GiV, gigantocellular reticular nucleus; LHb, lateral habenula; M1, primary motor cortex; LC, locus coeruleus; PB, parabrachial area;
VTA, ventral tegmental area; TMN, tuberomammillary nucleus.
(B) Example images showing the overlap between eGFP and Fos expression in three groups of mice (at AP 3.7 mm). In each group, wake- or sleep-active
neurons were first labeled with eGFP by pairing 4-OHT injection with SD or RS, respectively (Figure 1A). One week later, the mouse was sacrificed immediately
following RS or SD for Fos immunohistochemistry. Scale bar, 100 mm. Blue, DAPI; green, eGFP; red, anti-Fos immunohistochemistry. Lower panels show
enlarged views of regions in white boxes. Arrowheads indicate cells co-labeled with eGFP and Fos.
(C) Mean numbers of eGFP neurons in pIII of SD and RS mice. Error bar, SEM (n = 5 mice each).
(D) Efficiency and specificity of eGFP labeling in RS mice (mean ± SEM, n = 3 mice).
(E) Quantification of overlap between eGFP and Fos expression (mean ± SEM) in the three groups of mice shown in (B), n = 3 mice per group.
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Figure S2. Optogenetic Identification of CALCA Neurons in the pIII Region, Related to Figure 2
(A) Reliability and temporal jitter of laser-evoked spikes in identified (blue) and unidentified (gray) units recorded in the pIII. Note that the identified and unidentified
units form two distinct clusters, with high reliability and low jitter for identified units.
(B) Distribution of latencies of laser-evoked spiking for all identified CALCA neurons. Latency is defined as the timing of the first spike after each laser pulse.
(C) Distribution of Pearson correlation coefficients between laser-evoked and spontaneous spike waveforms for all identified units.
(legend on next page)
Figure S3. Locations of pIII CALCA Neurons Targeted for Optogenetic Activation/Inactivation, Effects of Their Activation/Inactivation on
Brain State Transition Probability, Control Optogenetic and Chemogenetic Experiments, and the Effect of Ablating pIII CALCA Neurons,
Related to Figure 3
(A) Left, fluorescence image of ChR2-eYFP expression in pIII (red box in coronal diagram, at AP 3.7 mm). Blue, DAPI; green, eYFP. Scale bar, 100 mm. Right,
summary of ChR2-eYFP expression inCalcaCremice. For eachmouse (n = 8mice), we determined the spread of ChR2-eYFP in 4 brain sections (from3.6mm to
4.2 mm along the rostrocaudal axis, where most of the virus expression was observed). The green color code indicates in how many mice the virus was
expressed at the corresponding location. Blue dots indicate the locations of optic fiber tips.
(B) Similar to (A), for iC++-eYFP.
(C) Effect of optogenetic activation of CALCA neurons on transition probability between each pair of brain states. Each bar represents transition probability within
each 20 s period (averaged across 3 consecutive 20 s bins within each 60 s). Error bar, 95%CI. Dashed line, baseline transition probability. N, NREM; R, REM;W,
wake.Wake/REM and REM/N transitions are omitted because they were rarely detected with or without laser stimulation. Magenta/cyan asterisk (*) indicates
significant increase/decrease in transition probability during laser stimulation compared to baseline (p < 0.05, bootstrap). The diagram summarizes transitions
that are significantly increased (magenta) or decreased (cyan) by laser stimulation.
(D) Similar to (C), for optogenetic inactivation.
(E) Left, effect of 20 Hz laser stimulation in CalcaCre-eYFP control mice. Shown is the percentage of time in NREM, REM, or wake state before, during, and after
laser stimulation (120 s), averaged from 5mice. Shading, 95%CI. Blue stripe, laser stimulation period. Right, for 60 s constant illumination (matching optogenetic
inactivation protocol).
(F) Effect of CNO inCalcaCremice expressingmCherry only. Shown is the percentage of time in each brain state following CNOor vehicle injection. Horizontal axis,
time after CNO/vehicle injection. Error bar, ±SEM; n = 6mice. There was no significant difference between CNO and vehicle injections (p > 0.39, 0.07, and 0.42 for
NREM, REM and wake respectively for all data points; two-way ANOVA with Bonferroni correction).
(G) Ablation of pIII CALCA neurons. Left, schematic of virus injection into pIII. Middle, example images (at AP3.8 mm) showing FISH ofCalca (red) in pIII of mice
injected with AAV-DIO-mCherry (control) or AAV-DIO-taCasp3-TEVp. Blue, DAPI. Scale bar, 100 mm. Right, ratio between the number of Calca-positive cells in
mice injected with AAV-DIO-taCasp3-TEVp and that in their control litter mates injected with AAV-DIO-mCherry. Each symbol indicates one pair of litter mates.
(H) Effect of ablating CALCA neurons on sleep time. Shown is the percentage of time in each brain state over a 24 hr cycle in mice injected with control virus and
AAV-DIO-taCasp3-TEVp. Error bar, ± SEM; n = 6 mice each. *p < 0.05; **p < 0.01; ***p < 0.001 (two-way ANOVA with Bonferroni correction).
(I) Similar to (H), during recovery sleep after 5 hr of sleep deprivation.
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Figure S4. Optogenetic Activation of pIII Neurons in Slc17a6Cre and CalcaCre Mice at High Laser Powers, Related to Figure 4
(A) Laser stimulation at 3-5 mW in Slc17a6Cre mice. Shown is the percentage of time in NREM, REM, or wake state before, during, and after laser stimulation,
averaged from 5 mice. Shading, 95% CI. Blue stripe, laser stimulation period (20 Hz, 120 s). Laser stimulation significantly decreased NREM sleep (p < 0.0001,
bootstrap) and increased wakefulness (p < 0.0001).
(B) Laser stimulation at 10 mW in CalcaCre mice (n = 4 mice). Laser stimulation significantly increased NREM sleep (p < 0.0001, bootstrap) and decreased
wakefulness (p < 0.0001) and REM sleep (p < 0.0001).
(legend on next page)
Figure S5. Percentage of Sleep-Active Neurons that Are CCK and CALCA Neurons, Locations of pIII CCK Neurons Targeted for Optogenetic
Activation and Inactivation, Effects of Their Activation and Inactivation on Brain State Transition Probability, Control for the Optogenetic
Experiment, and the Effect of Activating CCK Neurons at High Laser Power, Related to Figure 5
(A) Left/middle, example images showing the overlap between eGFP labeling of CALCA/CCK neurons and Fos expression in RS mice detected im-
munohistochemically (at AP 3.8 mm). Scale bar, 100 mm. Blue, DAPI; green, eGFP; red, anti-Fos immunohistochemistry. Arrowheads indicate cells co-labeled
with eGFP and Fos. Right, percentage of Fos+ neurons that are CALCA or CCK neurons. Each symbol represents one brain sample. Bar, mean ± SEM.
(B) Summary of ChR2-eYFP expression inCckCremice. For each mouse (n = 8 mice), we determined the spread of ChR2-eYFP in 3 brain sections (from3.8 mm
to 4.2 mm along the rostrocaudal axis, where most of the virus expression was observed). The green color code indicates in how many mice the virus was
expressed at the corresponding location. Blue dots indicate the locations of optic fiber tips.
(C) Similar to (B), for iC++-eYFP.
(D) Effect of optogenetic activation of CCK neurons on transition probability between each pair of brain states. Each bar represents transition probability within
each 20 s period (averaged across 3 consecutive 20 s bins within each 60 s). Error bar, 95% CI. Dashed line, baseline transition probability. N, NREM; R, REM;
W, wake. Wake/REM and REM/N transitions are omitted because they were rarely detected with or without laser stimulation. Magenta/cyan asterisk (*)
indicates significant increase/decrease in transition probability during laser stimulation compared to baseline (p < 0.05, bootstrap). The diagram summarizes
transitions that are significantly increased (magenta) or decreased (cyan) by laser stimulation.
(E) Similar to (D), for optogenetic inactivation.
(F) Effect of laser stimulation (20 Hz and constant illumination) inCckCre-eYFP control mice. Shown is the percentage of time in NREM, REM, or wake state before,
during, and after laser stimulation (120 s or 60 s), averaged from 5 mice. Shading, 95% CI. Blue stripe, laser stimulation period.
(G) Effect of laser stimulation at 10 mW in CckCre mice (n = 4 mice). Laser stimulation significantly increased NREM sleep (p < 0.0001, bootstrap) and decreased
wakefulness (p < 0.0001) and REM sleep (p < 0.0001).
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Figure S6. Control for Rabies-Mediated Transsynaptic Tracing, Related to Figure 6
(A) Control experiments for rabies-mediated transsynaptic retrograde tracing in CalcaCre mice. Left, schematic of virus injection. Middle, fluorescence image of
pIII in a CalcaCremouse (box in coronal diagram, at AP3.8 mm). Right, region in white box showing starter cells (expressing both eGFP and mCherry, indicated
by arrowheads); Blue, DAPI. Scale bar, 100 mm. Bar graph shows the numbers of starter cells and presynaptic neurons. Each line indicates data from one mouse
(n = 4 mice).
(B) Similar to (A), for control experiment in CckCre mice (n = 4 mice). Shown is a coronal image at AP 3.8 mm.
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Figure S7. Long-Range Projections of CCK and CALCANeurons to Other Regions, Lack of Projection fromCholinergic and Galaninergic pIII
Neurons to the POA and Posterior Medulla, Local Chemogenetic Activation of CALCA Neuron Axons in the POA and Medulla, and Dual
Retrograde Tracing from the POA and Medulla, Related to Figure 7
(A) Optogenetic activation of CCK neuron axons in the LH and LS had no effect. Left, fluorescence image of LH or LS (red box in coronal diagram) in a CckCre
mouse injected with AAV-DIO-ChR2-eYFP into the pIII. Blue, DAPI. LH, lateral hypothalamus; LS, lateral septum. Scale bar, 100 mm. Right, percentage of time in
NREM, REM, or wake state before, during, and after laser stimulation, averaged from 4mice. Shading, 95%CI. Blue stripe, laser stimulation period (20 Hz, 120 s).
(B) Similar to (A), for optogenetic activation of CALCA neuron axons in the MV and LH. MV, medial vestibular nucleus. n = 4 mice.
(C) Fluorescence images of pIII, POA, and posterior ventromedial medulla (red box in coronal diagram) in a ChatCremouse injected with AAV-DIO-ChR2-eYFP in
pIII, showing no projection to the POA or posterior ventromedial medulla. py, pyramidal tract. GiV, gigantocellular reticular nucleus.
(D) Similar to (C), for a GalCre mouse.
(E) Local chemogenetic activation of CALCA neuron axons in the POA. Shown is the percentage of time in each brain state following CNO or vehicle injection in
CalcaCremice expressing hM3D(Gq). Horizontal axis, time after CNO/vehicle injection. Error bar, ± SEM; n = 5 mice. *p < 0.05; **p < 0.001 (two-way ANOVA with
Bonferroni correction).
(F) Similar to (E) for local chemogenetic activation of CALCA neuron axons in the posterior ventromedial medulla. n = 5 mice.
(G) Left, schematic for dual retrograde tracing of pIII glutamatergic projections to the POA and medulla. Middle, fluorescence image of the pIII showing eYFP and
mCherry expression (at AP 3.8 mm). Right, number of neurons labeled by eYFP, mCherry, or both.
